Skip to content
Search

Latest Stories

Hancock terms situation 'concerning' as UK sees nearly 3,000 new cases in 24 hours

THE United Kingdom registered almost 3,000 new coronavirus cases over 24 hours, a level not seen since late May, health ministry figures showed on Sunday (6).

The government said two more people had died after testing positive over the past 28 days, bringing the overall UK toll to 41,551, Europe's highest. In addition, 2,988 new cases were recorded, significantly higher than the 1,813 registered on Saturday.


"The rise in the number of cases that we have seen today is concerning," said Health Secretary Matt Hancock as Britain digested the highest number of daily cases since 2,959 on May 23.

Hancock said the latest sufferers are predominantly young people but cautioned against behaviour that might allow a spread to the elderly.

Hancock said it was "important that people don't allow this illness to infect their grandparents and to lead to the sort of problems that we saw earlier in the year" when the health system battled to contain the virus as the toll inexorably rose.

The concern is that increased transmission generally heightens the risk that the virus could get passed on to the elderly and people with underlying health problems.

Opposition Labour health spokesman Jonathan Ashworth urged Hancock to update lawmakers on the government's approach in parliament on Monday.

Prime Minister Boris Johnson's Conservative government says it will tighten local restrictions in areas showing sharp rises in cases rather than impose a second national lockdown for fear of its effect on the economy.

Such restrictions would include limiting household contacts.

Sunday saw 124 new admissions to hospital of virus sufferers, bringing the total to 756 with 69 on ventilators.

'Virus is still with us'

To date, a total of 347,152 coronavirus cases have now been confirmed across the United Kingdom.

How to deal with the virus spread just as the school year starts remains a delicate question in many countries. Some parents question if it safe for their offspring to return to the classroom.

Hancock said the British government was right to reopen schools "because of the impact on children of not getting an education".

London's mayor Sadiq Khan expressed concern at the latest "worrying" transmission data.

"Londoners have already made incredible sacrifices but the virus is still with us & we must keep following the rules to keep safe," he tweeted.

Beyond the headline figure for Britain on Sunday, Scotland recorded 208 new cases for its highest daily increase in more than four months."

Cities are struggling with the economic impact of the virus, with millions of people having spent months working from home.

"The economy needs to have people back at work," Foreign Secretary Dominic Raab told the BBC.

"It is important to send a message that we need to get Britain back up and running, the economy motoring on all cylinders."

But he accepted that a mass return to office working would need to be "incremental".

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less